Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOND Study: Benfotiamine vs placebo in type 2 diabetes with polyneuropathy
2017-003054-16Phase 2Completed
- Sponsor
- Wörwag Pharma
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM) comparing Benfotiamine arm with Placebo arm (2 arms). Primary endpoint: Corneal nerve fiber length (CNFL) by corneal confocal microscopy (CCM). Started Apr 2018; status: completed.
02
Drugs
benfotiamine
03
Conditions
diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2017-003054-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003054-16.